$167 Million is the total value of Iguana Healthcare Management, LLC's 60 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABT | New | ABBOTT LABS | $4,417,000 | – | 115,000 | +100.0% | 2.64% | – |
| New | ISHARES TRput | $3,371,000 | – | 25,000 | +100.0% | 2.02% | – | |
| WBA | New | WALGREENS BOOTS ALLIANCE INC | $2,897,000 | – | 35,000 | +100.0% | 1.73% | – |
| AGN | New | ALLERGAN PLC | $2,625,000 | – | 12,500 | +100.0% | 1.57% | – |
| New | WALGREENS BOOTS ALLIANCE INCcall | $2,069,000 | – | 25,000 | +100.0% | 1.24% | – | |
| REGN | New | REGENERON PHARMACEUTICALS | $1,836,000 | – | 5,001 | +100.0% | 1.10% | – |
| AAAP | New | ADVANCED ACCELERATOR APPLICsponsored ads | $1,606,000 | – | 60,000 | +100.0% | 0.96% | – |
| MYL | New | MYLAN N V | $1,526,000 | – | 40,000 | +100.0% | 0.91% | – |
| New | ASTRAZENECA PLCcall | $1,366,000 | – | 50,000 | +100.0% | 0.82% | – | |
| AZN | New | ASTRAZENECA PLCsponsored adr | $1,366,000 | – | 50,000 | +100.0% | 0.82% | – |
| ACRS | New | ACLARIS THERAPEUTICS INC | $1,357,000 | – | 50,000 | +100.0% | 0.81% | – |
| DXCM | New | DEXCOM INC | $1,194,000 | – | 20,000 | +100.0% | 0.71% | – |
| New | SPDR SERIES TRUSTcall | $888,000 | – | 15,000 | +100.0% | 0.53% | – | |
| HZNP | New | HORIZON PHARMA PLC | $809,000 | – | 50,000 | +100.0% | 0.48% | – |
| RARX | New | RA PHARMACEUTICALS INC | $760,000 | – | 50,000 | +100.0% | 0.45% | – |
| AKAOQ | New | ACHAOGEN INC | $651,000 | – | 50,000 | +100.0% | 0.39% | – |
| DPLO | New | DIPLOMAT PHARMACY INC | $630,000 | – | 50,000 | +100.0% | 0.38% | – |
| MYOV | New | MYOVANT SCIENCES LTD | $622,000 | – | 50,000 | +100.0% | 0.37% | – |
| XBI | New | SPDR SERIES TRUSTs&p biotech | $592,000 | – | 10,000 | +100.0% | 0.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 17 | Q1 2018 | 7.5% |
| ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
| MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
| CELGENE CORP | 15 | Q4 2017 | 7.9% |
| AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
| GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
| ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
| SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
| DERMIRA INC | 14 | Q1 2018 | 2.7% |
| AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-16 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| 13F-HR/A | 2016-11-17 |
| 13F-HR | 2016-11-14 |
| 13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.